Home

About the Forum

Forum Projects

Publications & Reports

Collaborations& Databases

Special Events

Special Announcements

Support the Forum

Employment/Internship Opportunities

Links

The George Washington University Medical Center

3rd International Workshop on Structured Treatment Interruption

Follow up Roundtable Discussion: Recommendations for a Specific Research Agenda

Background:

The Forum was a co-sponsor of the 3rd International Workshop on Structured Treatment Interruptions, held on March 22-24, 2002 in Montreal, Canada. Other sponsors were: FAIR, Project Inform, TAG, and GMHC. Approximately 80 scientists and community advocates gathered to present and discuss new data and issues surrounding treatment interruptions used in various settings, focusing on specific issues surrounding treatment interuptions. The following topics were discussed: Therapeutic Immunization and Immune Modulation, Immune Escape, STI and Drug Resistance in Salvage Patients, STI and Drug Resistance in Virologically Suppressed Patients and Drug-Sparing Strategies and Toxicity Reduction.

The Forum sponsored a follow-up smaller Roundtable to discuss and recommend a specific research agenda for treatment interruptions.

Objectives:

The Roundtable discussion focused on three topics:

  • Analytic uses of STI’s in the development of immune-based treatments and/or strategies,
  • Drug sparing strategies,
  • Patients with multi-drug resistant virus.

Three questions were posed for each topic: What research gaps exist and which questions need answering? What collaborations, new initiatives or other activities are necessary for this agenda to move forward? What funding mechanisms neet to be put into place for the agenda to move forward?

Status:

The reports for the STI III Workshop and the Follow-Up Roundtable Discussion are now available on our website.

Project Specific Sponsoring: The STI Workshop in Montreal was sponsored by Abbott Laboratories, Agouron, Bristol-Myers Squibb, Forum for Collaborative HIV Research, Gilead Pharmaceuticals, GlaxoSmithKline, Roche Pharmaceuticals, Treatment Action Group, ViroLogic.

A grant from Chiron Corporation funded the follow-up Roundtable.

 

Forum for Collaborative HIV Research
Department of Prevention and Community Health
School of Public Health and Health Services

2175 K St NW Ste 700
Washington, DC 20037
Phone: 202 530-2370
Fax: 202 530-3923
info@hivforum.org

The Forum for Collaborative HIV Research